Accrufer (ferric maltol)
Adakveo (crizanlizumab)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) is a medication used for the treatment of patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
This is the first approved antidote for apixaban- or rivaroxaban-treated patients with uncontrolled bleeds.
Cablivi
Evrenzo (roxadustat)
Feraccru (ferric maltol)
Givlaari (givosiran)
Inrebic (fedratinib)
Inrebic (fedratinib) is a medication used for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.
This medicine is not (yet) part of our standard product range but we may be able to get it for you. The packaging size and strength below may vary due to product availability. Please contact us to verify price and availability.
Ondexxya (andexanet alfa)
Ondexxya (andexanet alfa) is a medication used for the treatment of patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
This is the first approved antidote for apixaban- or rivaroxaban-treated patients with uncontrolled bleeds.
Oxbryta (voxelotor)
Oxbryta (voxelotor) is a hemoglobin S polymerization inhibitor indicated for the treatment of sickle cell disease in adults and children 12 years of age and older.
This medicine is not (yet) part of our standard product range but we may be able to get it for you. The packaging size and strength below may vary due to product availability. Please contact us to verify price and availability.
NOTE: This medicine can only be purchased on behalf of a hospital. Additional documents may be required. Please contact us for details.
Reblozyl (luspatercept)
